Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · IEX Real-Time Price · USD
13.89
-0.23 (-1.63%)
At close: Jul 2, 2024, 4:00 PM
13.35
-0.54 (-3.89%)
After-hours: Jul 2, 2024, 5:49 PM EDT
Avadel Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for AVDL stock have an average target of 24.17, with a low estimate of 21 and a high estimate of 29. The average target predicts an increase of 74.01% from the current stock price of 13.89.
Analyst Consensus: Strong Buy
* Price targets were last updated on May 9, 2024.
Analyst Ratings
The average analyst rating for AVDL stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jan '24 | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 |
---|---|---|---|---|---|---|
Strong Buy | 3 | 4 | 5 | 5 | 4 | 4 |
Buy | 3 | 3 | 3 | 3 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 6 | 7 | 8 | 8 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +58.39% | May 9, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $25 → $27 | Strong Buy | Maintains | $25 → $27 | +94.38% | May 9, 2024 |
Craig-Hallum | Craig-Hallum | Strong Buy Maintains $22 → $23 | Strong Buy | Maintains | $22 → $23 | +65.59% | May 9, 2024 |
Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +58.39% | May 8, 2024 |
Needham | Needham | Strong Buy Reiterates $22 | Strong Buy | Reiterates | $22 | +58.39% | Apr 9, 2024 |
Financial Forecast
Revenue This Year
171.69M
from 27.96M
Increased by 513.99%
Revenue Next Year
305.36M
from 171.69M
Increased by 77.86%
EPS This Year
-0.52
from -2.00
EPS Next Year
0.79
from -0.52
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 193.7M | 350.4M | 470.5M | 538.5M | 583.8M |
Avg | 171.7M | 305.4M | 408.2M | 481.3M | 531.0M |
Low | 155.7M | 243.0M | 305.8M | 421.0M | 466.3M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | 592.6% | 104.1% | 54.1% | 31.9% | 21.3% |
Avg | 514.0% | 77.9% | 33.7% | 17.9% | 10.3% |
Low | 456.9% | 41.6% | 0.1% | 3.1% | -3.1% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.07 | 2.15 | 3.54 | 3.15 | 3.62 |
Avg | -0.52 | 0.79 | 1.85 | 2.44 | 2.81 |
Low | -0.74 | -0.03 | 0.89 | 1.75 | 2.02 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | 347.1% | 70.3% | 48.3% |
Avg | - | - | 133.7% | 32.1% | 15.0% |
Low | - | - | 12.7% | -5.2% | -17.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.